Omuro A, Brandes AA, Carpentier AF, Idbaih A, et al. Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial. Neuro Oncol 2022 Apr 14. pii: 6568419. doi: 10.1093.
PMID: 35419607